BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28780404)

  • 1. The Likelihood of Remnant Nonfunctioning Pituitary Adenomas Shrinking Is Associated with the Lesion's Blood Supply Pattern.
    Ito M; Kuge A; Matsuda KI; Sato S; Kayama T; Sonoda Y
    World Neurosurg; 2017 Nov; 107():137-141. PubMed ID: 28780404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor shrinkage after transsphenoidal surgery for nonfunctioning pituitary adenoma.
    Berkmann S; Schlaffer S; Buchfelder M
    J Neurosurg; 2013 Dec; 119(6):1447-52. PubMed ID: 24074495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten years' experience with intraoperative MRI-assisted transsphenoidal pituitary surgery.
    Hlaváč M; Knoll A; Mayer B; Braun M; Karpel-Massler G; Etzrodt-Walter G; Coburger J; Wirtz CR; Paľa A
    Neurosurg Focus; 2020 Jun; 48(6):E14. PubMed ID: 32480376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative high-field MRI for transsphenoidal reoperations of nonfunctioning pituitary adenoma.
    Berkmann S; Schlaffer S; Nimsky C; Fahlbusch R; Buchfelder M
    J Neurosurg; 2014 Nov; 121(5):1166-75. PubMed ID: 25127413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic Transsphenoidal Surgery Outcomes in 331 Nonfunctioning Pituitary Adenoma Cases After a Single Surgeon Learning Curve.
    Kim JH; Lee JH; Lee JH; Hong AR; Kim YJ; Kim YH
    World Neurosurg; 2018 Jan; 109():e409-e416. PubMed ID: 29017983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early postoperative MRI and detection of residual adenoma after transsphenoidal pituitary surgery.
    Alhilali LM; Little AS; Yuen KCJ; Lee J; Ho TK; Fakhran S; White WL
    J Neurosurg; 2020 Feb; 134(3):761-770. PubMed ID: 32032952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risks and Benefits of Endoscopic Transsphenoidal Surgery for Nonfunctioning Pituitary Adenomas in Patients of the Ninth Decade.
    Chinezu R; Fomekong F; Lasolle H; Trouillas J; Vasiljevic A; Raverot G; Jouanneau E
    World Neurosurg; 2017 Oct; 106():315-321. PubMed ID: 28676462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of ultra-low-field intraoperative magnetic resonance imaging on extent of resection and frequency of tumor recurrence in 104 surgically treated nonfunctioning pituitary adenomas.
    Hlavica M; Bellut D; Lemm D; Schmid C; Bernays RL
    World Neurosurg; 2013 Jan; 79(1):99-109. PubMed ID: 23043996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
    Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER
    J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary surgery and volumetric assessment of extent of resection: a paradigm shift in the use of intraoperative magnetic resonance imaging.
    Serra C; Burkhardt JK; Esposito G; Bozinov O; Pangalu A; Valavanis A; Holzmann D; Schmid C; Regli L
    Neurosurg Focus; 2016 Mar; 40(3):E17. PubMed ID: 26926057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transition From Microscopic to Endoscopic Transsphenoidal Surgery for Nonfunctional Pituitary Adenomas.
    Karppinen A; Kivipelto L; Vehkavaara S; Ritvonen E; Tikkanen E; Kivisaari R; Hernesniemi J; Setälä K; Schalin-Jäntti C; Niemelä M
    World Neurosurg; 2015 Jul; 84(1):48-57. PubMed ID: 25731792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proposal and Validation of a Simple Grading Scale (TRANSSPHER Grade) for Predicting Gross Total Resection of Nonfunctioning Pituitary Macroadenomas After Transsphenoidal Surgery.
    Mooney MA; Sarris CE; Zhou JJ; Barkhoudarian G; Chicoine MR; Fernandez-Miranda JC; Gardner PA; Hardesty DA; Jahnke H; Kelly DF; Liebelt BD; Mayberg MR; Prevedello DM; Sfondouris J; Sheehy JP; Chandler JP; Yuen KCJ; White WL; Little AS;
    Oper Neurosurg (Hagerstown); 2019 Nov; 17(5):460-469. PubMed ID: 30649445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
    Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
    J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 10 Years' Experience of Using Low-Field Intraoperative MRI in Transsphenoidal Surgery for Pituitary Adenoma: Results of the Swiss Pituitary Registry (SwissPit).
    Strange F; Remonda L; Schütz P; Fandino J; Berkmann S
    World Neurosurg; 2020 Apr; 136():e284-e293. PubMed ID: 31899402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of high-resolution intraoperative MRI in endoscopic transsphenoidal surgery for pituitary macroadenomas: early experience in the Advanced Multimodality Image Guided Operating suite.
    Zaidi HA; De Los Reyes K; Barkhoudarian G; Litvack ZN; Bi WL; Rincon-Torroella J; Mukundan S; Dunn IF; Laws ER
    Neurosurg Focus; 2016 Mar; 40(3):E18. PubMed ID: 26926058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Value of Intraoperative Magnetic Resonance Imaging in Endoscopic and Microsurgical Transsphenoidal Pituitary Adenoma Resection.
    Pal'a A; Knoll A; Brand C; Etzrodt-Walter G; Coburger J; Wirtz CR; Hlaváč M
    World Neurosurg; 2017 Jun; 102():144-150. PubMed ID: 28286276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and outcomes of null-cell versus silent gonadotroph adenomas in a series of 1166 pituitary adenomas from a single institution.
    Haddad AF; Young JS; Oh T; Pereira MP; Joshi RS; Pereira KM; Osorio RC; Donohue KC; Peeran Z; Sudhir S; Jain S; Beniwal A; Chopra AS; Sandhu NS; Theodosopoulos PV; Kunwar S; El-Sayed IH; Gurrola J; Blevins LS; Aghi MK
    Neurosurg Focus; 2020 Jun; 48(6):E13. PubMed ID: 32480370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance and Indications of Surgery for Asymptomatic Nonfunctioning Pituitary Adenomas.
    Ogiwara T; Nagm A; Nakamura T; Mbadugha T; Horiuchi T; Hongo K
    World Neurosurg; 2019 Aug; 128():e752-e759. PubMed ID: 31077893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor shrinkage assessed by volumetric MRI in long-term follow-up after fractionated stereotactic radiotherapy of nonfunctioning pituitary adenoma.
    Kopp C; Theodorou M; Poullos N; Jacob V; Astner ST; Molls M; Grosu AL
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1262-7. PubMed ID: 21530099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiologic Predictors for Extent of Resection in Pituitary Adenoma Surgery. A Single-Center Study.
    Sanmillán JL; Torres-Diaz A; Sanchez-Fernández JJ; Lau R; Ciller C; Puyalto P; Gabarrós A
    World Neurosurg; 2017 Dec; 108():436-446. PubMed ID: 28899832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.